Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.

dc.contributor.author	Minagawa, Kentaro
dc.contributor.author	Jamil, Muhammad O
dc.contributor.author	Al-Obaidi, Mustafa
dc.contributor.author	Pereboeva, Larisa
dc.contributor.author	Salzman, Donna
dc.contributor.author	Erba, Harry P
dc.contributor.author	Lamb, Lawrence S
dc.contributor.author	Bhatia, Ravi
dc.contributor.author	Mineishi, Shin
dc.contributor.author	Di Stasi, Antonio
dc.date.accessioned	2019-12-01T17:50:37Z
dc.date.available	2019-12-01T17:50:37Z
dc.date.issued	2017-01
dc.date.updated	2019-12-01T17:50:35Z
dc.description.abstract	[This corrects the article DOI: 10.1371/journal.pone.0166891.].
dc.identifier	PONE-D-17-05236
dc.identifier.issn	1932-6203
dc.identifier.issn	1932-6203
dc.identifier.uri	https://hdl.handle.net/10161/19548
dc.language	eng
dc.publisher	Public Library of Science (PLoS)
dc.relation.ispartof	PloS one
dc.relation.isversionof	10.1371/journal.pone.0172640
dc.subject	Science & Technology
dc.subject	Multidisciplinary Sciences
dc.subject	Science & Technology - Other Topics
dc.title	Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.
dc.type	Journal article
duke.contributor.orcid	Erba, Harry P\|0000-0003-1093-2189
pubs.begin-page	e0172640
pubs.issue	2
pubs.organisational-group	School of Medicine
pubs.organisational-group	Duke
pubs.organisational-group	Duke Cancer Institute
pubs.organisational-group	Institutes and Centers
pubs.publication-status	Published
pubs.volume	12

Files

Now showing 1 - 1 of 1

Name:: Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.pdf
Size:: 276.6 KB
Format:: Adobe Portable Document Format